Neurogene (NGNE) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts NGNE Hot Sheet
Join SI Premium – FREE
Neurogene (NASDAQ: NGNE) reported Q3 EPS of ($1.19), in-line with the analyst estimate of ($1.19).
For earnings history and earnings-related data on Neurogene (NGNE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DigitalOcean projects record Q2 2026 results with RPO above $800M
- Alamar Biosciences launches eMTBR-Tau blood test for Alzheimer's
- Benchmark Reiterates Buy Rating on Kyivstar Group (KYIV) Following Recent Rally
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
